AI-generated summary
The authors ran a prospective, double-masked, placebo-controlled study in which one eye of each of 28 participants received intense pulsed light to the periocular area and the partner eye received placebo. They report that lipid layer grade, tear break-up time and symptom scores improved in treated eyes but not control eyes, while tear evaporation rate and tear meniscus height did not change. The authors describe the results as showing therapeutic potential for meibomian gland dysfunction.
- Participants
- 28
- Who or what was studied
- 28 participants with meibomian gland dysfunction, each contributing a treated eye and a placebo-treated partner eye
- Limits stated in the abstract
- The abstract does not state a sample size calculation, follow-up beyond day 45, or the certainty of the evidence.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on iovs.arvojournals.org.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: GRADE, Visual analogue scale, Placebo-controlled, Dry eye. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.